ATE299375T1 - Dextrinhaltige zusammensetzungen zur vermeidung von adhäsionen - Google Patents

Dextrinhaltige zusammensetzungen zur vermeidung von adhäsionen

Info

Publication number
ATE299375T1
ATE299375T1 AT01901267T AT01901267T ATE299375T1 AT E299375 T1 ATE299375 T1 AT E299375T1 AT 01901267 T AT01901267 T AT 01901267T AT 01901267 T AT01901267 T AT 01901267T AT E299375 T1 ATE299375 T1 AT E299375T1
Authority
AT
Austria
Prior art keywords
compositions containing
preventing adhesions
adhesions
dextrine
containing dextrine
Prior art date
Application number
AT01901267T
Other languages
English (en)
Inventor
Susan Conroy
Original Assignee
Ml Lab Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0001352A external-priority patent/GB0001352D0/en
Priority claimed from GB0015035A external-priority patent/GB2363713A/en
Application filed by Ml Lab Plc filed Critical Ml Lab Plc
Application granted granted Critical
Publication of ATE299375T1 publication Critical patent/ATE299375T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/718—Starch or degraded starch, e.g. amylose, amylopectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04—Macromolecular materials
    • A61L31/042—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Surgery (AREA)
  • Vascular Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
AT01901267T 2000-01-21 2001-01-19 Dextrinhaltige zusammensetzungen zur vermeidung von adhäsionen ATE299375T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0001352A GB0001352D0 (en) 2000-01-21 2000-01-21 Prevention of adhesions
GB0015035A GB2363713A (en) 2000-06-21 2000-06-21 Dextrin compositions
PCT/GB2001/000193 WO2001052866A1 (en) 2000-01-21 2001-01-19 Dextrin containing compositions for prevention of adhesions

Publications (1)

Publication Number Publication Date
ATE299375T1 true ATE299375T1 (de) 2005-07-15

Family

ID=26243442

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01901267T ATE299375T1 (de) 2000-01-21 2001-01-19 Dextrinhaltige zusammensetzungen zur vermeidung von adhäsionen

Country Status (13)

Country Link
US (1) US8455464B2 (de)
EP (1) EP1248636B1 (de)
JP (1) JP4999247B2 (de)
KR (1) KR100740735B1 (de)
AT (1) ATE299375T1 (de)
AU (1) AU2001226926A1 (de)
CA (1) CA2392666C (de)
DE (1) DE60111921T2 (de)
DK (1) DK1248636T3 (de)
ES (1) ES2245974T3 (de)
HK (1) HK1048433B (de)
PT (1) PT1248636E (de)
WO (1) WO2001052866A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9810127D0 (en) * 1998-05-13 1998-07-08 Ml Lab Plc Prevention of surgical adhesions
JP4566189B2 (ja) 2004-03-15 2010-10-20 テルモ株式会社 癒着防止材
US8252333B2 (en) 2006-01-26 2012-08-28 Jorge Cueto-Garcia Biodegradable, non-toxic biological adhesive for use in abdominal surgery
KR101444291B1 (ko) * 2013-01-16 2014-09-26 경북대학교병원 설페이트 전분을 포함하는 복막투석액용 삼투압제 및 이를 포함하는 복막투석용 조성물
CN111643519A (zh) * 2020-06-29 2020-09-11 华仁药业股份有限公司 一种伤口消毒液及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5605938A (en) * 1991-05-31 1997-02-25 Gliatech, Inc. Methods and compositions for inhibition of cell invasion and fibrosis using dextran sulfate
US5318780A (en) * 1991-10-30 1994-06-07 Mediventures Inc. Medical uses of in situ formed gels
US5891418A (en) * 1995-06-07 1999-04-06 Rhomed Incorporated Peptide-metal ion pharmaceutical constructs and applications
NZ507832A (en) * 1998-05-13 2003-03-28 Ml Lab Plc Dextrin-containing composition for preventing surgical adhesions
MXPA02001472A (es) 1999-08-10 2002-07-02 Ml Lab Plc Metodo para suministrar agentes terapeuticos utilizando una solucion de dextrina.

Also Published As

Publication number Publication date
CA2392666A1 (en) 2001-07-26
US20030153529A1 (en) 2003-08-14
ES2245974T3 (es) 2006-02-01
PT1248636E (pt) 2005-11-30
CA2392666C (en) 2011-12-13
US8455464B2 (en) 2013-06-04
JP2003520243A (ja) 2003-07-02
JP4999247B2 (ja) 2012-08-15
DK1248636T3 (da) 2005-11-07
EP1248636B1 (de) 2005-07-13
KR100740735B1 (ko) 2007-07-19
HK1048433B (en) 2005-12-23
EP1248636A1 (de) 2002-10-16
KR20030005160A (ko) 2003-01-17
AU2001226926A1 (en) 2001-07-31
WO2001052866A1 (en) 2001-07-26
HK1048433A1 (en) 2003-04-04
DE60111921D1 (de) 2005-08-18
DE60111921T2 (de) 2006-07-20

Similar Documents

Publication Publication Date Title
MY127247A (en) New pharmaceutical composition
ATE321836T1 (de) Wässrige zusammensetzungen für oberflächebehandlung
DE60123389D1 (de) Stabile, wässerige zusammensetzungen zur behandlung von oberflächen , insbesondere geweben
HRP20030037A2 (en) Nail varnish composition
ATE293463T1 (de) Zusammensetzung und verfahren zur entkeimung von luft
EP1438481B8 (de) Gegenseitige lösungsmittel für hochkonzentrierte behandlungsflüssigkeiten
DE60005688D1 (de) Verfahren zur behandlung von chronischem schmerz durch verabreichung von einem mek hemmer
DE602005022914D1 (de) Beschichtungszusammensetzung und verfahren
ES2162925T3 (es) Agentes tensioactivos de copolimeros en bloque de oxido de butileno y oxido de etileno como revestimientos estabilizadores para formulaciones nanocristalinas.
ATE448775T1 (de) Rifalazil zur behandlung von infektionen mit clostridium difficile
EP1622608A4 (de) Zusammensetzungen und verfahren zur behandlung von krebs
DK1117440T3 (da) Farmaceutiske sammensætninger indeholdende paclitaxel
ATE229340T1 (de) Relaxinartiger faktor und damit zusammenhängende verfahren und verwendungen
DE60107252D1 (de) Antimikrobielle zusammensetzung zur behandlung von rindermastitis
DE50112128D1 (de) Retardpartikeldispersion
MXPA05000785A (es) Composicion y proceso para tratar manchas.
ATE516027T1 (de) Orazamid orotat zur vorbeugung von leberschäden
DE60038802D1 (de) Zusammensetzungen und Verfahren zur Behandlung von Oberflächen
IL144199A0 (en) Novel bretylium compositions and kits, and their use in preventing and treating cardiovascular conditions
DE60111921D1 (de) Dextrinhaltige zusammensetzungen zur vermeidung von adhäsionen
EE04711B1 (et) Antiseptiline kompositsioon, puidust või muust materjalist põhimiku töötlemismeetod, puidu või muu materjali kaitsmismeetod, oksatiasiini ühendi, pluss ühe või mitme kvaternaarse ammooniumiühendi ja triasooliühendi kasutamine
ATE356626T1 (de) Gelzusammensetzung auf alkoholischer basis zur behandlung von hypogonadismus durch transskrotale applikation
ATE275100T1 (de) Sequestrierung
BR9911769A (pt) Composições que contêm dextrina para prevenir as aderências cirúrgicas
ATE460168T1 (de) Nicht-radioaktives strontiummittel zur behandlung von krebs

Legal Events

Date Code Title Description
EEFA Change of the company name
UEP Publication of translation of european patent specification

Ref document number: 1248636

Country of ref document: EP

EEFA Change of the company name